BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34380040)

  • 1. Cell-to-cell variability in JAK2/STAT5 pathway components and cytoplasmic volumes defines survival threshold in erythroid progenitor cells.
    Adlung L; Stapor P; Tönsing C; Schmiester L; Schwarzmüller LE; Postawa L; Wang D; Timmer J; Klingmüller U; Hasenauer J; Schilling M
    Cell Rep; 2021 Aug; 36(6):109507. PubMed ID: 34380040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin and Friend virus gp55 activate different JAK/STAT pathways through the erythropoietin receptor in erythroid cells.
    Yamamura Y; Senda H; Kageyama Y; Matsuzaki T; Noda M; Ikawa Y
    Mol Cell Biol; 1998 Mar; 18(3):1172-80. PubMed ID: 9488432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total saponins of Panax ginseng (TSPG) promote erythroid differentiation of human CD34+ cells via EpoR-mediated JAK2/STAT5 signaling pathway.
    Chen D; Zuo G; Li C; Hu X; Guan T; Jiang R; Li J; Lin X; Li F; Luo C; Wang H; Lei C; Long X; Wang Y; Wang J
    J Ethnopharmacol; 2009 Nov; 126(2):215-20. PubMed ID: 19735711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.
    Tong W; Zhang J; Lodish HF
    Blood; 2005 Jun; 105(12):4604-12. PubMed ID: 15705783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin induces sustained phosphorylation of STAT5 in primitive but not definitive erythrocytes generated from mouse embryonic stem cells.
    Tsuji-Takayama K; Otani T; Inoue T; Nakamura S; Motoda R; Kibata M; Orita K
    Exp Hematol; 2006 Oct; 34(10):1323-32. PubMed ID: 16982325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin can induce the expression of bcl-x(L) through Stat5 in erythropoietin-dependent progenitor cell lines.
    Silva M; Benito A; Sanz C; Prosper F; Ekhterae D; Nuñez G; Fernandez-Luna JL
    J Biol Chem; 1999 Aug; 274(32):22165-9. PubMed ID: 10428780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JAK2 V617F stimulates proliferation of erythropoietin-dependent erythroid progenitors and delays their differentiation by activating Stat1 and other nonerythroid signaling pathways.
    Shi J; Yuan B; Hu W; Lodish H
    Exp Hematol; 2016 Nov; 44(11):1044-1058.e5. PubMed ID: 27473563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Division of labor by dual feedback regulators controls JAK2/STAT5 signaling over broad ligand range.
    Bachmann J; Raue A; Schilling M; Böhm ME; Kreutz C; Kaschek D; Busch H; Gretz N; Lehmann WD; Timmer J; Klingmüller U
    Mol Syst Biol; 2011 Jul; 7():516. PubMed ID: 21772264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three Tyrosine Residues in the Erythropoietin Receptor Are Essential for Janus Kinase 2 V617F Mutant-induced Tumorigenesis.
    Ueda F; Tago K; Tamura H; Funakoshi-Tago M
    J Biol Chem; 2017 Feb; 292(5):1826-1846. PubMed ID: 27998978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The JAK kinase inhibitor CP-690,550 suppresses the growth of human polycythemia vera cells carrying the JAK2V617F mutation.
    Manshouri T; Quintás-Cardama A; Nussenzveig RH; Gaikwad A; Estrov Z; Prchal J; Cortes JE; Kantarjian HM; Verstovsek S
    Cancer Sci; 2008 Jun; 99(6):1265-73. PubMed ID: 18482053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients.
    Akagi S; Ichikawa H; Okada T; Sarai A; Sugimoto T; Morimoto H; Kihara T; Yano A; Nakao K; Nagake Y; Wada J; Makino H
    J Am Soc Nephrol; 2004 Dec; 15(12):3215-24. PubMed ID: 15579525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JAK2/STAT5/Bcl-xL signalling is essential for erythropoietin-mediated protection against apoptosis induced in PC12 cells by the amyloid β-peptide Aβ25-35.
    Ma R; Hu J; Huang C; Wang M; Xiang J; Li G
    Br J Pharmacol; 2014 Jul; 171(13):3234-45. PubMed ID: 24597613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation.
    Arcasoy MO; Harris KW; Forget BG
    Exp Hematol; 1999 Jan; 27(1):63-74. PubMed ID: 9923445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin receptor-dependent erythroid colony-forming unit development: capacities of Y343 and phosphotyrosine-null receptor forms.
    Miller CP; Heilman DW; Wojchowski DM
    Blood; 2002 Feb; 99(3):898-904. PubMed ID: 11806992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel role for STAT1 in regulating murine erythropoiesis: deletion of STAT1 results in overall reduction of erythroid progenitors and alters their distribution.
    Halupa A; Bailey ML; Huang K; Iscove NN; Levy DE; Barber DL
    Blood; 2005 Jan; 105(2):552-61. PubMed ID: 15213094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-stimulation with stem cell factor and erythropoietin enhances migration of c-Kit expressing cervical cancer cells through the sustained activation of ERK1/2.
    Aguilar C; Aguilar C; Lopez-Marure R; Jiménez-Sánchez A; Rocha-Zavaleta L
    Mol Med Rep; 2014 May; 9(5):1895-902. PubMed ID: 24626629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lyn kinase plays important roles in erythroid expansion, maturation and erythropoietin receptor signalling by regulating inhibitory signalling pathways that control survival.
    Slavova-Azmanova NS; Kucera N; Louw A; Satiaputra J; Handoko A; Singer P; Stone L; McCarthy DJ; Klinken SP; Hibbs ML; Ingley E
    Biochem J; 2014 May; 459(3):455-66. PubMed ID: 24552351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epo-induced hemoglobinization of SKT6 cells is mediated by minimal cytoplasmic domains of the Epo or prolactin receptors without modulation of GATA-1 or EKLF.
    Reese TT; Gregory RC; Sharlow ER; Pacifici RE; Crouse JA; Todokoro K; Wojchowski DM
    Growth Factors; 1997; 14(2-3):161-76. PubMed ID: 9255607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin induces tyrosine phosphorylation of the interleukin-3 receptor beta subunit (betaIL3) and recruitment of Stat5 to possible Stat5-docking sites in betaIL3.
    Chin H; Wakao H; Miyajima A; Kamiyama R; Miyasaka N; Miura O
    Blood; 1997 Jun; 89(12):4327-36. PubMed ID: 9192755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.